AbbVie, Inc. (ABBV)
224.35
-4.37
(-1.91%)
USD |
NYSE |
Feb 19, 16:00
224.75
+0.40
(+0.18%)
Pre-Market: 06:03
AbbVie Free Cash Flow : 19.68B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 8.10B |
| Biogen, Inc. | 1.969B |
| Gilead Sciences, Inc. | 10.02B |
| Johnson & Johnson | 19.70B |
| Eli Lilly & Co. | 5.964B |